Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hormone Refractory Prostate Cancer 1

Interventions

radium Ra 223 dichloride 2 gossypol acetic acid 1 bafetinib 1 Mycobacterium w vaccine 1 Docetaxel 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Hormone Refractory Prostate Cancer × bafetinib × Clear all

NCT01215799 2011-12-15

PROACT

CytRx

Phase 2 Completed

Hormone Refractory Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡